Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan.
about
KASL clinical practice guidelines: management of chronic hepatitis BEmerging hepatitis B virus infection in vaccinated populations: a rising concern?Viral infections of the fetus and newborn infantAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Hepatitis B and C viruses are not risks for pancreatic adenocarcinomaImmunisation against hepatitis B in Taiwan.Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients.Predictors for early HBeAg loss during lamivudine therapy in HBeAg-positive chronic hepatitis B patients with acute exacerbationHepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study.Profile of Ding-Shinn Chen.Occult and Overt HBV Co-Infections Independently Predict Postoperative Prognosis in HCV-Associated Hepatocellular Carcinoma.Prevention of hepatitis B.Presentation of autoantibody to proliferating cell nuclear antigen in patients with chronic hepatitis B and C virus infection.Different hepatitis B virus core gene mutations in children with chronic infection and hepatocellular carcinomaSurvey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan.KASL Clinical Practice Guidelines: Management of chronic hepatitis B.Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and CHepatitis B therapy in children.What physicians should know about the management of chronic hepatitis B in children: East side story.Natural history of hepatitis B virus infection: pediatric perspective.Cost-effectiveness analysis of prophylactic lamivudine use in preventing vertical transmission of hepatitis B virus infection.Management of chronic hepatitis B in children: an unresolved issue.Improving clinical outcomes of chronic hepatitis B virus infection.A review of strategies to prevent mother-to-infant transmission of hepatitis B virus infection.Chronologic changes in serum hepatitis B virus DNA, genotypes, surface antigen mutants and reverse transcriptase mutants during 25-year nationwide immunization in Taiwan.Epidemiology of hepatitis B virus infection in the Asia-Pacific region.Fighting against viral hepatitis: lessons from Taiwan.Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries.Intra-familial spread of hepatitis B virus infection in eastern Turkey.Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals.Natural history of chronic hepatitis B virus infection in childhood and efficacy of interferon therapy.Universal infant immunization and occult hepatitis B virus infection in children and adolescents: a population-based study.Estimating numbers of persons with persistent hepatitis B virus infection transmitted vertically and horizontally in the birth cohort during 1950-1985 in Japan.Viral infection, human papillomavirus DNA, and cervical neoplasia.Chronic hepatitis virus infection in children.Impact of universal vaccination on intrafamilial transmission of hepatitis B virus.Secular trend of the viral genotype distribution in children with chronic hepatitis B virus infection after universal infant immunization.Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan.Toll-like receptor and hepatitis B virus clearance in chronic infected patients: a long-term prospective cohort study in Taiwan.
P2860
Q26752475-8656329C-C99F-4449-8121-6BAF4E2B219EQ27012663-E2FB9C9B-1D62-44AD-8C14-5A690A970CA3Q27488781-FC105E72-60DA-4E20-BE80-E2B5616ABCDFQ30391932-89FF6F8C-066B-4CC3-9BC1-BD5CAC105BF4Q33564208-C19B01B9-81F9-4C12-B44D-FCA258B9F712Q34442054-C74D738B-53D3-4A9D-A9AC-5C8EE3C05A99Q34551114-F1B85674-15BD-4778-A9AB-3C1D8CF59CC4Q34553545-78FD9C68-BB6A-4FC9-99DB-058FDA4AB594Q34581747-4473EC31-163B-4CE7-9675-85E5BE24E554Q34689074-24FB20A3-279C-4A04-B94B-2F38961023FFQ34785204-D182F797-35C0-40FA-9F74-8F133E1E2834Q35164249-85DD57A7-FC35-4760-A582-E4B00CAAC37DQ35548278-DE8649F4-1DB8-45A5-90FD-7AFFEF8B7200Q35595295-39B30D88-E627-458C-B19E-9D0FE0DB2318Q35596881-D7494A15-0F36-4765-96C4-72B47742430EQ36153966-A609ADE7-19FF-4FF4-A42A-D4E1A04F31DCQ36920164-3017F538-B997-4F1E-ADA6-B5F957A6F36FQ37390647-2BED9B6F-C801-4260-BCCA-C5D8DFD928A4Q37682515-AD701285-3A19-4711-8816-13063C1F0B9FQ37784738-798D562D-015E-4ADE-8EA8-47630B041EBDQ37955240-98A4E7AA-983D-4537-9FA3-C4FDB9C5EA70Q38215076-884922AB-E9FB-472C-8EC2-6CB74BE29C02Q38252962-4B5435CB-619D-4D3C-BBCE-A368D1ABCD63Q38632945-84CED354-D298-4C38-88FA-BA13D4F7C317Q38969885-B90B8E2B-BEA6-4A5D-AFD6-4472DCADC782Q39543484-71602081-379C-4CB0-865F-A3FA914AC67DQ39733406-439C510C-58BA-4793-A8CB-62F0142B4CAEQ40143078-D4FEDAE8-483B-485E-B618-D1341C2ED804Q40197931-EBC9C9B7-ECCE-45F2-A16F-6CD6165AC713Q40240656-B9B332D0-D9CD-40C1-A82F-913B1837BB2CQ40320642-8E969726-6541-48AE-966C-E368C6AA2A52Q41345009-4A59353A-81BB-4C96-AC3B-545CB9AE94C5Q41602121-BA3FB9E5-783A-41EE-84D9-9DB15B67FDD0Q42237972-8EF919CF-355B-450C-91E5-16D3EDD3FF51Q42735514-6A919F6C-710B-4589-98D0-D72CC1291404Q42988714-B7983CF4-3D99-49E4-88E4-4941405A9A29Q43508386-FE149D68-A759-4863-B0F6-6C8D258D49C4Q44034326-5349EF67-CAF5-4417-BC57-97D99A26EF66Q44584276-8C0D560F-3DCE-41F4-8176-C46DDED4141DQ44674221-7B7FCF3F-0318-4E6C-8099-6ED2F5CC920B
P2860
Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Baseline seroepidemiology of h ...... vaccination program in Taiwan.
@en
Baseline seroepidemiology of h ...... vaccination program in Taiwan.
@nl
type
label
Baseline seroepidemiology of h ...... vaccination program in Taiwan.
@en
Baseline seroepidemiology of h ...... vaccination program in Taiwan.
@nl
prefLabel
Baseline seroepidemiology of h ...... vaccination program in Taiwan.
@en
Baseline seroepidemiology of h ...... vaccination program in Taiwan.
@nl
P2093
P356
P1476
Baseline seroepidemiology of h ...... vaccination program in Taiwan
@en
P2093
P2860
P304
P356
10.1002/JMV.1890180402
P577
1986-04-01T00:00:00Z